(Q37577663)

21 August 2017

1 reference

title

Neuroprotection and neurogeneration in MS and its animal model EAE effected by glatiramer acetate (English)

1 reference

21 August 2017

1

Ruth Arnon

1 reference

21 August 2017

2

Rina Aharoni

1 reference

21 August 2017

publication date

11 August 2009

1 reference

Journal of Neural Transmission

21 August 2017

published in

1 reference

21 August 2017

volume

116

1 reference

21 August 2017

issue

11

1 reference

21 August 2017

page(s)

1443-1449

1 reference

Glatiramer acetate reduces the proportion of new MS lesions evolving into "black holes".

21 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00702-009-0272-3

CNS neurotrophins are biologically active and expressed by multiple cell types

21 January 2018

1 reference

12 December 2020

BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells?

1 reference

12 December 2020

Lower brain-derived neurotrophic factor in serum of relapsing remitting MS: reversal by glatiramer acetate

1 reference

12 December 2020

Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy. Brain-derived neurotrophic factor

1 reference

12 December 2020

Glatiramer acetate in multiple sclerosis: update on potential mechanisms of action

1 reference

12 December 2020

Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease

1 reference

12 December 2020

Transient expression of doublecortin during adult neurogenesis

1 reference

12 December 2020

Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group

1 reference

12 December 2020

Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences

1 reference

12 December 2020

Multiple sclerosis: comparison of copolymer-1- reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells

1 reference

12 December 2020

Mechanisms and time course of neuronal degeneration in experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Neurotrophic factors and clinical recovery in relapsing-remitting multiple sclerosis.

1 reference

12 December 2020

Axonal damage is reduced following glatiramer acetate treatment in C57/bl mice with chronic-induced experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Remyelination in multiple sclerosis: a new role for neurotrophins?

1 reference

12 December 2020

The development of Cop 1 (Copaxone), an innovative drug for the treatment of multiple sclerosis: personal reflections

1 reference

12 December 2020

Specific Th2 cells accumulate in the central nervous system of mice protected against experimental autoimmune encephalomyelitis by copolymer 1

1 reference

12 December 2020

Glatiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factorin situ

1 reference

12 December 2020

Axonal pathology in multiple sclerosis. A historical note

1 reference

12 December 2020

Molecular signals regulating proliferation of stem and progenitor cells in mouse olfactory epithelium

1 reference

12 December 2020

Understanding CNS remyelination: clues from developmental and regeneration biology

1 reference

12 December 2020

Glatiramer acetate-reactive T cells produce brain-derived neurotrophic factor

1 reference

12 December 2020

Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease

1 reference

12 December 2020

Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP

1 reference

12 December 2020

Copolymer 1 induces T cells of the T helper type 2 that crossreact with myelin basic protein and suppress experimental autoimmune encephalomyelitis

1 reference

12 December 2020

T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies

1 reference

12 December 2020

The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice

1 reference

12 December 2020

Neurotrophin secretion: current facts and future prospects

1 reference

12 December 2020

Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease

1 reference

12 December 2020

Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma

1 reference

12 December 2020

A prospective open-label study of glatiramer acetate: over a decade of continuous use in multiple sclerosis patients

1 reference

12 December 2020

Functional neurogenesis in the adult hippocampus

1 reference

12 December 2020

TGF-?-treated microglia induce oligodendrocyte precursor cell chemotaxis through the HGF-c-Met pathway

1 reference

12 December 2020

Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation

1 reference

12 December 2020

Directed migration of neuronal precursors into the ischemic cerebral cortex and striatum

1 reference

12 December 2020

Experimental autoimmune encephalomyelitis mobilizes neural progenitors from the subventricular zone to undergo oligodendrogenesis in adult mice

1 reference

12 December 2020

Neurogenesis and neuroprotection induced by peripheral immunomodulatory treatment of experimental autoimmune encephalomyelitis.

1 reference

12 December 2020

A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions

1 reference

12 December 2020

Direct binding of myelin basic protein and synthetic copolymer 1 to class II major histocompatibility complex molecules on living antigen-presenting cells--specificity and promiscuity.

1 reference

12 December 2020

Induction of neurogenesis in the neocortex of adult mice

1 reference

12 December 2020

Immunomodulation by the copolymer glatiramer acetate

1 reference

12 December 2020

Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Axonal metabolic recovery and potential neuroprotective effect of glatiramer acetate in relapsing-remitting multiple sclerosis

1 reference

12 December 2020

Insights into the immunopathogenesis of multiple sclerosis

1 reference

12 December 2020

10.1007/S00702-009-0272-3

Identifiers

DOI

1 reference

release_mhyatnzviveafa3ygva4vfuv5e

21 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mhyatnzviveafa3ygva4vfuv5e

24 November 2022

mapped directly with Wikidata item

1 reference